Fibrin sealant produced by the CryoSeal® FS System: Product chemistry, material properties and possible preparation in the autologous preoperative setting

Vox Sanguinis

Volumn 86, Issue 4, 2004, Pages 257-262

  Buchta, Christoph ^a   Dettke, M ^a   Funovics, P T ^b   Hocker P ^a   Knobl P ^b   Macher, M ^a   Quehenberger, P ^b   Treitl, C ^a   Worel, N ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; FIBRIN GLUE; FIBRINOGEN;

ARTICLE; CHEMICAL ANALYSIS; CLINICAL PRACTICE; COMPARATIVE STUDY; CRYOPRECIPITATE; GOOD MANUFACTURING PRACTICE; LABORATORY TEST; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; THROMBOELASTOGRAPHY;

BLOOD COMPONENT REMOVAL; DISPOSABLE EQUIPMENT; ELASTICITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EQUIPMENT DESIGN; FACTOR XIII; FIBRIN; FIBRIN TISSUE ADHESIVE; FIBRINOGEN; FIBRONECTINS; FRACTIONAL PRECIPITATION; FREEZING; HUMANS; MATERIALS TESTING; PLASMA; THROMBELASTOGRAPHY; THROMBIN;

EID: 3142624405     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0042-9007.2004.00516.x     Document Type: Article

References (32)

1. Carless PA, Anthony DM, Henry DA: Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion. Br J Surg 2002; 89:695-703
2. Reiss RF, Oz MC: Autologous fibrin glue: production and clinical use. Transfus Med Rev 1996; 10:85-92
3. Mankad PS, Codispoti M: The role of fibrin glue in hemostasis. Am J Surg 2001; 182S: 21-28
4. Amrani DL, Diorio JP, Delmotte Y: Wound healing. Role of commercial fibrin sealants. Ann NY Acad Sci 2001; 936:566-579
5. Currie LJ, Sharpe JR, Martin R: The use of fibrin glue in skin grafts and tissue-engineered skin replacements: a review. Plast Reconstr Surg 2001; 108:1713-1726
6. Jackson MR: Fibrin sealants in surgical practice: an overview. Am J Surg 2001; 182S: 1-7
7. Kawamura M, Sawafuji M, Watanabe M, Horinouchi H, Kobayashi K: Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgery. Ann Thorac Surg 2002; 73:1098-1100
8. Evatt B, Austin H, Leon G, Ruiz-Saez A, de Bosch N: Hemophilia treatment. Predicting the long-term risk of HIV exposure by cryoprecipitate. Haemophilia 2000; 6:128-132
9. Hunter N, Houston F: Can prion diseases be transmitted between individuals via blood transfusion: evidence from sheep experiments. Dev Biol (Basel) 2002; 108:93-98
10. Anon: Monograph 4.00/0903, European Pharmacopoeia, 4th edn. Strasbourg, European Directorate for the Quality of Medicines, 2002
11. Rock G, Berger R, Lange J, Tokessy M, Palmer DS, Giulivi A: A novel, automated method of temperature cycling to produce cryoprecipitate. Transfusion 2001; 41:232-235
12. Pool JG, Shannon AE: Production of high potency concentrates of antihemophilic globulin in a closed bag system. N Engl J Med 1965; 273:1443-1447
13. Preston AE, Barr A: The plasma concentration of Factor VIII in the normal population. II. The effects of age, sex and blood group. Br J Haematol 1964; 10:238
14. Hartert H: Thrombelastography; in Bang U et al. (eds): Thrombosis and Bleeding Disorders. New York, London, G. Thieme Verlag, Stuttgart, Academic Press, 1971:70-76
15. Dadeya S: Strabismus surgery: fibrin glue versus vicryl for conjuctival closure. Acta Ophthalmol Scand 2001; 79:515-517
16. Davis BR, Sandor GK: Use of fibrin glue in maxillofacial surgery. J Otolaryngol 1998; 27:107-112
17. Kumar U, Albala DM: Fibrin glue applications in urology. Curr Urol Rep 2001; 2:79-82
18. Noun R, Elias D, Balladur P, Bismuth H, Parc R, Lasser P, Belghiti J: Fibrin sealant effectiveness and tolerance after elective liver resection: a randomized trial. Hepato-Gastroenterology 1996; 43:221-224
19. Codispoti M, Mankad PS: Significant merits of a fibrin sealant in the prenence of coagulopathy following pediatric cardiac surgery: randomised controlled trial. Eur J Cardiothorac Surg 2002; 22:200-205
20. Moore M, Burak WE Jr, Nelson E, Kearney T, Simmons R, Mayers L, Spotnitz WD: Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. J Am Coll Surg 2001; 192:591-599
21. Komatsu F, Yoshida S: Large volume apheresis of autologous plasma and prepartion of autologous fibrin glue from the plasma. Ther Apher 2001; 5:12-16
22. Casali B, Rodeghiero F, Tosetto A, Palmieri B, Immovilli R, Ghedini C, Rivasi P: Fibrin glue from single-donation autologous plasmapheresis. Transfusion 1992; 32:641-643
23. Wan HL, Huang ST, Floyd DM, McGowan EI, Feldman DS: Is the amount of fibrinogen in cryoprecipitate adequate for fibrin glue? Introducing an improved recycled cryoprecipitate method. Transfusion 1989; 29:41S
24. Kjaergard HK, Weis-Fogh US: Important factors influencing the strength of autologous fibrin glue; the fibrin concentration and reaction time - comparison of strength with sommercial firin glue. Eur Surg Res 1994; 26:273-276
25. Stenn KS, DePalma L: Re-epithelialization; in Clark, RAF, Henson, PM (eds): The Molecular and Cellular Biology of Wound Repair. New York, Plenum Press, 1988:321-336
26. Dickneite G, Metzner HJ, Kroez M, Hein B, Nicolay U: The importance of Factor XIII as a component of fibrin sealants. J Surg Res 2002; 107:186-195
27. Oz MC, Jeevanandam V, Smith CR, Williams MR, Kaynar AM, Frank RA, Mosca R, Reiss RF, Rose EA: Autologous fibrin glue from intraoperatively collected platelet-rich plasma. Ann Thorac Surg 1992; 53:530-531
28. Glidden PF, Malaska C, Herring SW: Thrombelastograph assay for measuring the mechanical strength of fibrin sealant clots. Clin Appl Thromb Hemost 2000; 6:226-233
29. Fay WP, Owen WG: Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein C. Biochemistry 1989; 28:5773-5778
30. Gibble JW, Ness PM: Fibrin glue: the perfect operative sealant? Transfusion 1990; 30:741-747
31. Seelich T: Tissucol® (Immuno, Vienna): Biochemistry and methods of application. J Head Neck Pathol 1982; 3:65-69
32. Knöbl P, Lechner K: Acquired factor V inhibitors. Balliere's Clin Haematol 1998; 11:305-318